日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists

去胞壁酰肽 NOD2 激动剂的结构改变驱动的独特免疫特征

Špela Janež, Samo Guzelj, Petra Kocbek, Eveline A de Vlieger, Bram Slütter, Žiga Jakopin

Linker Chemistry and Connectivity Fine-Tune the Immune Response and Kinetic Solubility of Conjugated NOD2/TLR7 Agonists

连接基团化学和连接方式可微调共轭NOD2/TLR7激动剂的免疫反应和动力学溶解度

Janež, Špela; Guzelj, Samo; Jakopin, Žiga

The Effect of Body Temperature Changes on the Course of Treatment in Patients With Pneumonia and Sepsis: Results of an Observational Study

体温变化对肺炎和脓毒症患者治疗过程的影响:一项观察性研究的结果

Guzelj, Domen; Grubelnik, Anže; Greif, Nina; Povalej Bržan, Petra; Fluher, Jure; Kalamar, Žiga; Markota, Andrej

Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines

新型佐剂组合的初步结果表明,其可增强全灭活流感疫苗的免疫原性。

Peletta, Allegra; Marmy, Aurélie; Guzelj, Samo; Ramos Barros, Alcidia; Jakopin, Žiga; Borchard, Gerrit

Corrigendum: Preliminary results on novel adjuvant combinations suggest enhancement immunogenicity of whole inactivated pandemic influenza vaccines

更正:新型佐剂组合的初步结果表明,可增强全灭活流感大流行疫苗的免疫原性。

Peletta, Allegra; Marmy, Aurélie; Guzelj, Samo; Ramos Barros, Alcidia; Jakopin, Žiga; Borchard, Gerrit

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators

共价结合的 NOD2/TLR7 激动剂是强效且多功能的免疫增强剂

Samo Guzelj, Matjaž Weiss, Bram Slütter, Ruža Frkanec, Žiga Jakopin

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity

NOD2激动剂经金刚烷和硬脂酰基脂化修饰后,其体内佐剂活性受到不同的调控。

Guzelj, Samo; Šišić, Marcela; Bizjak, Špela; Frkanec, Leo; Frkanec, Ruža; Jakopin, Žiga

Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening

通过基于药效团的虚拟筛选鉴定出用于调节 NOD2 的新型支架

Samo Guzelj, Tihomir Tomašič, Žiga Jakopin

Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells

核苷酸结合寡聚化结构域 1/Toll 样受体 4 共同参与促进针对 K562 癌细胞的非特异性免疫反应

Samo Guzelj, Žiga Jakopin

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity

去胞壁酰肽 NOD2 激动剂的结构微调决定了其体内佐剂活性

Samo Guzelj, Sanja Nabergoj, Martina Gobec, Stane Pajk, Veronika Klančič, Bram Slütter, Ruža Frkanec, Adela Štimac, Primož Šket, Janez Plavec, Irena Mlinarič-Raščan, Žiga Jakopin